Gelesis, in collaboration with MCPHS University, is offering a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry.
Gelesis is developing a novel hydrogel platform technology to treat overweight/obesity and chronic diseases related to the GI pathway. In April 2019, Gelesis received FDA clearance for its lead product candidate, Plenity®, for weight management in adults with overweight and obesity. Pipeline candidates based on the Gelesis hydrogel platform technology are also being advanced for the management of type 2 diabetes, non-alcoholic steatohepatitis (NASH) and chronic idiopathic constipation (CIC). Gelesis was named one of Fast Company’s Most Innovative Biotechnology Companies for 2020.
About the MCPHS/Gelesis fellowship program:
The two-year Gelesis Medical Affairs (MA) fellowship offers prospective candidates the opportunity to gain unique experience and training with a leading-edge biotechnology company. The MA fellow will play an essential role in supporting the commercialization of a first-in-class therapeutic product for obesity management, Plenity®. The Gelesis fellow can expect to gain experience and lead projects across the medical affairs functional area, including those relating to medical information, publication planning, scientific conferences, pharmacovigilance, and key opinion leader engagement.
Gelesis offers a supportive environment for the professional growth and development of PharmD fellows. The Gelesis program director is an alumnus and past director with the MCPHS Biopharmaceutical Industry Fellowship program. Members of the Gelesis executive team – namely the CSO and COO – are also PharmD professionals with extensive industry experience.
This will be a non-rotational Medical Affairs fellowship. The fellow will be integrated into existing workstreams. Responsibilities and projects will evolve organically as the therapeutic products they support advance through their lifecycle.
The fellow will be responsible for a number of long-term projects:
- Develop a medical information toolset (FAQs, standardized response letters, educational presentations) to support the commercial launch of a weight management therapeutic
- Develop and manage a scientific congress engagement plan for the Medical Affairs team
- Write a scientific manuscript for publication
The initial months of the fellowship will be dedicated to onboarding and foundational learning. Following the extended onboarding, the fellow and preceptor will develop a mutually agreed upon set of goals for the next six months. Formal evaluations and feedback sessions will take place every 6 months, in accordance with the process followed at Gelesis. One-on-one preceptor interactions will take place at least every two weeks.
During the first year, the MA fellow will support core medical affairs functional responsibilities, including medical information, scientific communications, and pharmacovigilance. As the progress into their second year of fellowship, the MA fellow will continue to provide core functional support with increasing levels of responsibility and will be expected to lead their own projects and work streams.
Involvement with MCPHS:
All fellows will be paired with a faculty member on any one of the three MCPHS University campuses for their 1st year. The fellow will work with their faculty mentor to determine teaching and scholarly activities, with approval from the Gelesis preceptor. Fellows are required to teach and produce scholarship annually.
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program. Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
- All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided.
How to Apply:
Visit Workforce Now to apply. All candidates will be required to provide:
- Letter of intent
- Curriculum vitae
- Unofficial college transcript
Final candidates will be notified to provide two letters of recommendations to firstname.lastname@example.org